Catalent Inc (NYSE: CTLT) kicked off on Tuesday, down -0.35% from the previous trading day, before settling in for the closing price of $59.46. Over the past 52 weeks, CTLT has traded in a range of $32.38-$61.20.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 12.75% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 342.00%. With a float of $178.26 million, this company’s outstanding shares have now reached $181.00 million.
In an organization with 16900 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 21.82%, operating margin of 1.27%, and the pretax margin is -7.85%.
Catalent Inc (CTLT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Catalent Inc is 1.79%, while institutional ownership is 90.39%. The most recent insider transaction that took place on Nov 11 ’24, was worth 167,160. Before that another transaction happened on Oct 18 ’24, when Company’s SVP, General Counsel, CCO sold 320 for $59.97, making the entire transaction worth $19,190. This insider now owns 23,967 shares in total.
Catalent Inc (CTLT) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 342.00% per share during the next fiscal year.
Catalent Inc (NYSE: CTLT) Trading Performance Indicators
Take a look at Catalent Inc’s (CTLT) current performance indicators. Last quarter, stock had a quick ratio of 1.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.43. Likewise, its price to free cash flow for the trailing twelve months is 108.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.27, a number that is poised to hit 0.14 in the next quarter and is forecasted to reach 1.70 in one year’s time.
Technical Analysis of Catalent Inc (CTLT)
Let’s dig in a bit further. During the last 5-days, its volume was 2.27 million. That was better than the volume of 2.04 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 56.31%. Additionally, its Average True Range was 0.55.
During the past 100 days, Catalent Inc’s (CTLT) raw stochastic average was set at 63.69%, which indicates a significant increase from 49.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 12.50% in the past 14 days, which was higher than the 8.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $59.92, while its 200-day Moving Average is $57.68. However, in the short run, Catalent Inc’s stock first resistance to watch stands at $59.62. Second resistance stands at $59.99. The third major resistance level sits at $60.23. If the price goes on to break the first support level at $59.01, it is likely to go to the next support level at $58.77. Assuming the price breaks the second support level, the third support level stands at $58.40.
Catalent Inc (NYSE: CTLT) Key Stats
The company with the Market Capitalisation of 10.75 billion has total of 181,512K Shares Outstanding. Its annual sales at the moment are 4,381 M in contrast with the sum of -1,043 M annual income. Company’s last quarter sales were recorded 1,023 M and last quarter income was -129,000 K.
